These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24019492)

  • 1. Mechanism for activation of mutated epidermal growth factor receptors in lung cancer.
    Red Brewer M; Yun CH; Lai D; Lemmon MA; Eck MJ; Pao W
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3595-604. PubMed ID: 24019492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
    Monsey J; Shen W; Schlesinger P; Bose R
    J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain.
    Ozer BH; Wiepz GJ; Bertics PJ
    Oncogene; 2010 Feb; 29(6):855-64. PubMed ID: 19915609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Insight on WT- and Mutated-EGFR Receptor Activation and Inhibition by Epigallocatechin-3-Gallate: Over a Rational Basis for the Design of Selective Non-Small-Cell Lung Anticancer Agents.
    Minnelli C; Laudadio E; Mobbili G; Galeazzi R
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The juxtamembrane region of the EGF receptor functions as an activation domain.
    Red Brewer M; Choi SH; Alvarado D; Moravcevic K; Pozzi A; Lemmon MA; Carpenter G
    Mol Cell; 2009 Jun; 34(6):641-51. PubMed ID: 19560417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.
    Jia Y; Yun CH; Park E; Ercan D; Manuia M; Juarez J; Xu C; Rhee K; Chen T; Zhang H; Palakurthi S; Jang J; Lelais G; DiDonato M; Bursulaya B; Michellys PY; Epple R; Marsilje TH; McNeill M; Lu W; Harris J; Bender S; Wong KK; Jänne PA; Eck MJ
    Nature; 2016 Jun; 534(7605):129-32. PubMed ID: 27251290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the activation of oncogenic forms of EGF receptor.
    Wang Z; Longo PA; Tarrant MK; Kim K; Head S; Leahy DJ; Cole PA
    Nat Struct Mol Biol; 2011 Nov; 18(12):1388-93. PubMed ID: 22101934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.
    Cho J; Chen L; Sangji N; Okabe T; Yonesaka K; Francis JM; Flavin RJ; Johnson W; Kwon J; Yu S; Greulich H; Johnson BE; Eck MJ; Jänne PA; Wong KK; Meyerson M
    Cancer Res; 2013 Nov; 73(22):6770-9. PubMed ID: 24063894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
    Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
    Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
    Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
    Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
    Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
    Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic Amino Acids Within the Juxtamembrane Domain of the Epidermal Growth Factor Receptor Regulate Receptor Dimerization and Auto-phosphorylation.
    Mohr JD; Wagenknecht-Wiesner A; Holowka DA; Baird BA
    Protein J; 2020 Oct; 39(5):476-486. PubMed ID: 33211253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single ligand is sufficient to activate EGFR dimers.
    Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.
    Clayton AH; Walker F; Orchard SG; Henderson C; Fuchs D; Rothacker J; Nice EC; Burgess AW
    J Biol Chem; 2005 Aug; 280(34):30392-9. PubMed ID: 15994331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations.
    Littlefield P; Liu L; Mysore V; Shan Y; Shaw DE; Jura N
    Sci Signal; 2014 Dec; 7(354):ra114. PubMed ID: 25468994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors.
    Filosto S; Becker CR; Goldkorn T
    Mol Cancer Ther; 2012 Apr; 11(4):795-804. PubMed ID: 22302097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation by protein kinase Cε leads to modified responses of EGF receptor towards tyrosine kinase inhibitors.
    Weisheit S; Liebmann C
    Cell Signal; 2012 Feb; 24(2):422-434. PubMed ID: 21964064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
    Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
    Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
    Thiel KW; Carpenter G
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.
    Aertgeerts K; Skene R; Yano J; Sang BC; Zou H; Snell G; Jennings A; Iwamoto K; Habuka N; Hirokawa A; Ishikawa T; Tanaka T; Miki H; Ohta Y; Sogabe S
    J Biol Chem; 2011 May; 286(21):18756-65. PubMed ID: 21454582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.